USA to Support Vaccine Intellectual Property Waiver – COVID-19 Update – WHO (07 May 2021)

About This Source - United Nations

The United Nations (UN) was established after World War II with the aim of preventing future wars. The organization is financed by assessed and voluntary contributions from its member states.

The UN’s chief administrative officer is the Secretary-General, currently Portuguese politician and diplomat António Guterres, who began his five year-term on 1 January 2017.

 

Recent from United Nations:

  • António Guterres secures second term as UN Secretary-General
  • António Guterres on his appointment to a second term as UN chief – Media Stakeout (18 June 2021)
  • What is the role of the United Nations Secretary-General?
  • United Nations published this video item, entitled “USA to Support Vaccine Intellectual Property Waiver – COVID-19 Update – WHO (07 May 2021)” – below is their description.

    The US announcement to support a temporary waiver of intellectual property protections for COVID-19 vaccines is “a significant statement of solidarity and support for vaccine equity,” WHO chief Dr Tedros Ghebreyesus said on Friday (7 May), urging other countries “to follow their example.”

    “We are in an unprecedented crisis that requires unprecedented action,” Dr Tedros said. “Cases are at a record high, almost 100,000 people are dying globally each week, and we have a chronic vaccine crisis.”

    Insisting that the World Trade Organization provisions for Intellectual Property waivers were designed “precisely for a situation like this,” Dr Tedros asked, “if we don’t use them now, then when?”

    He also reminded that intellectual property waivers will need to be accompanied by transfer of technology and know-how for these difficult-to-make vaccines.

    Announcing the WHO’s Emergency Use Listing to Sinopharm Beijing’s COVID-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality, Dr Tedros said “the Strategic Advisory Group of Experts on Immunization, or SAGE, has also reviewed the available data, and recommends the vaccine for adults 18 years and older, with a two-dose schedule.”

    “Vaccines remain a vital tool,” Dr Tedros said. “But right now, the volume and distribution of vaccines is insufficient to end the pandemic, without the sustained and tailored application of public health measures that we know work.”

    United Nations YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • ‘That’s a private matter’: Biden on rebuke from Catholic bishops
  • ‘That’s a private matter’: Biden on rebuke from Catholic bishops
  • EU Lifts Travel Restrictions for Americans
  • Covid Cases Going Up in Places Where Vaccine Rates Are Low: Biden
  • President Joe Biden’s update on COVID-19 response
  • In This Story: Sinopharm

    China National Pharmaceutical Group Corp. known as Sinopharm is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine. Shanghai Shyndec Pharmaceutical and Beijing Tiantan Biological Products.

    2 Recent Items: Sinopharm

  • China approves Sinopharm and Sinovac jabs for emergency use for children aged 3 to 17
  • WHO-approved China-made vaccines: Impact on global COVID-19 response
  • Leave a Comment